Susquehanna International Group
AMRX icon

Susquehanna International Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Susquehanna International Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$126K – 13104
2025
Q4 		$126K Buy
+10,000
New +$114K ﹤0.01% 11313
2025
Q3 		– Sell
-37,400
Closed -$303K – 12294
2025
Q2 		$303K Sell
37,400
-13,000
-26% -$98K ﹤0.01% 10311
2025
Q1 		$422K Sell
50,400
-22,000
-30% -$184K ﹤0.01% 9282
2024
Q4 		$573K Buy
72,400
+25,600
+55% +$215K ﹤0.01% 8330
2024
Q3 		$389K Buy
46,800
+3,600
+8% +$28.2K ﹤0.01% 9049
2024
Q2 		$274K Sell
43,200
-22,300
-34% -$142K ﹤0.01% 9651
2024
Q1 		$397K Buy
+65,500
New +$369K ﹤0.01% 9054
2023
Q3 		– Sell
-33,100
Closed -$103K – 11950
2023
Q2 		$103K Buy
33,100
+18,800
+131% +$40K ﹤0.01% 10930
2023
Q1 		$19.9K Sell
14,300
-7,100
-33% -$14.1K ﹤0.01% 12054
2022
Q4 		$42.6K Sell
21,400
-64,900
-75% -$145K ﹤0.01% 11476
2022
Q3 		$174K Sell
86,300
-18,400
-18% -$51.6K ﹤0.01% 11037
2022
Q2 		$333K Sell
104,700
-147,900
-59% -$536K ﹤0.01% 9289
2022
Q1 		$1.05M Buy
252,600
+75,800
+43% +$336K ﹤0.01% 6978
2021
Q4 		$847K Sell
176,800
-210,700
-54% -$1.05M ﹤0.01% 7736
2021
Q3 		$2.07M Buy
387,500
+121,300
+46% +$611K ﹤0.01% 5756
2021
Q2 		$1.36M Buy
266,200
+20,200
+8% +$115K ﹤0.01% 6907
2021
Q1 		$1.66M Buy
246,000
+52,400
+27% +$290K ﹤0.01% 6381
2020
Q4 		$885K Buy
193,600
+94,400
+95% +$418K ﹤0.01% 6996
2020
Q3 		$385K Sell
99,200
-16,400
-14% -$70.1K ﹤0.01% 8212
2020
Q2 		$550K Buy
115,600
+14,900
+15% +$61.4K ﹤0.01% 7169
2020
Q1 		$350K Buy
100,700
+35,800
+55% +$152K ﹤0.01% 7680
2019
Q4 		$313K Sell
64,900
-99,000
-60% -$344K ﹤0.01% 7932
2019
Q3 		$475K Buy
163,900
+110,500
+207% +$386K ﹤0.01% 7414
2019
Q2 		$383K Buy
+53,400
New +$546K ﹤0.01% 7821
2018
Q3 		– Sell
-19,600
Closed -$322K – 9139
2018
Q2 		$322K Buy
+19,600
New +$344K ﹤0.01% 7689

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Susquehanna International Group's AMRX Position: Q1 2026 in Review

Susquehanna International Group reduced its Amneal Pharmaceuticals (AMRX) stake by 96% in Q1 2026, selling an estimated $17.1M and leaving 52,543 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #8974.

Susquehanna International Group first reported a position in AMRX in Q2 2018 and has held it in 29 quarters since. The position peaked at $16.7M in Q4 2025. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Susquehanna International Group held 52,543 shares of Amneal Pharmaceuticals worth $653K as of Q1 2026.
  • Susquehanna International Group sold 1,273,997 Amneal Pharmaceuticals shares in Q1 2026, an estimated $17.1M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8974 holding.
  • Susquehanna International Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 29 quarters since.
  • Susquehanna International Group's Amneal Pharmaceuticals position peaked at $16.7M in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.